Opening book details…
Can I read Euglycemic Diabetic Ketoacidosis in a Patient on Sodium-glucose Cotransporter 2 Inhibitors on EtoBox?
Euglycemic Diabetic Ketoacidosis in a Patient on Sodium-glucose Cotransporter 2 Inhibitors by Daniel B. Hammond; Claire C. Ingram is a Health Professions article available to read on EtoBox.
What is Euglycemic Diabetic Ketoacidosis in a Patient on Sodium-glucose Cotransporter 2 Inhibitors about?
## ABSTRACT Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel drug class for treating type 2 diabetes and are unique among diabetes medications because they increase urinary glucose excretion. SGLT2 inhibitors also have shown benefit beyond reducing blood glucose in patients with cardiovascular disease, renal disease, or heart failure. The American Diabetes Association recommends SGLT2 inhibitors for patients with type 2 diabetes who have one or more of these comorbidities. This article discusses one life-threatening adverse reaction to SGLT2 inhibitors, euglycemic diabetic ketoacidosis, and recommendations about patients on SGLT2 inhibitors who need surgery.
Who reads Euglycemic Diabetic Ketoacidosis in a Patient on Sodium-glucose Cotransporter 2 Inhibitors?
It is typically read by researchers, students, and practitioners in Health Professions.
- Author
- Daniel B. Hammond; Claire C. Ingram
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Published
- 2023
- Language
- EN
- Field
- Health Professions (Health Sciences)